FASN and colorectal carcinoma: The higher extent of FASN downregulation in mice with homozygous deletion leads to additional alterations in gene expression associated with inhibition of energy production, fatty acid biosynthesis, and CRC-promoting pathways, suggesting that a higher degree of FASN inhibition elicits a more efficient and global antitumor effect.